Wawa on Delaware River waterfront to get its own land-use hearing to handle big crowd - The Philadelphia Inquirer

-

Representatives of the Delaware River Waterfront Corp., a city-affiliated nonprofit that oversees waterfront development, and the Central Delaware Advocacy Group, a coalition of river-adjacent neighborhood associations, also voiced opposition, saying the development would counter efforts to make the waterfront more inviting to walkers and cyclists.



https://ift.tt/2o3FDaS

Comments

Post a Comment

Popular posts from this blog

Non-invasive prenatal testing: a revolutionary journey in prenatal testing

-
Image
factor ix deficiency :: Article Creator Novo Nordisk Files Long-acting Factor IX For Haemophilia B In US Novo Nordisk has filed its long-acting factor IX, nonacog beta pegol in the US for haemophilia B. Nonacog beta pegol is a glycopegylated recombinant factor IX with a longer half-life, developed for patients with haemophilia B. Novo said that the drug's half-life is five times longer than standard factor IX products, meaning fewer injections are needed. Although Novo has long had a presence in haemophilia, it faces competition in both haemophilia A and B. In haemophilia B, Biogen and Swedish Orphan Biovitrum have Alprolix (coagulation factor IX (recombinant)) approved in the EU and the US. The filing of nonacog beta pegol is based on the results from the PARADIGM clinical trial programme which involved 115 patients with severe or moderately severe haemophilia B. Nonacog beta pegol was found to be efficacious in routine prophylaxis, treat...
Read more